TRANSGENE SA (TNG.PA) Stock Fundamental Analysis

EPA:TNG • FR0005175080

0.856 EUR
-0.04 (-4.89%)
Last: Feb 26, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

1

Taking everything into account, TNG scores 1 out of 10 in our fundamental rating. TNG was compared to 77 industry peers in the Biotechnology industry. TNG has a bad profitability rating. Also its financial health evaluation is rather negative. TNG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • TNG had negative earnings in the past year.
  • In the past year TNG has reported a negative cash flow from operations.
  • TNG had negative earnings in each of the past 5 years.
  • In the past 5 years TNG always reported negative operating cash flow.
TNG.PA Yearly Net Income VS EBIT VS OCF VS FCFTNG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • TNG's Return On Assets of -82.88% is on the low side compared to the rest of the industry. TNG is outperformed by 70.13% of its industry peers.
Industry RankSector Rank
ROA -82.88%
ROE N/A
ROIC N/A
ROA(3y)-59.77%
ROA(5y)-43.73%
ROE(3y)-151.05%
ROE(5y)-103.3%
ROIC(3y)N/A
ROIC(5y)N/A
TNG.PA Yearly ROA, ROE, ROICTNG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for TNG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TNG.PA Yearly Profit, Operating, Gross MarginsTNG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • TNG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TNG has been increased compared to 1 year ago.
  • TNG has more shares outstanding than it did 5 years ago.
  • TNG has a better debt/assets ratio than last year.
TNG.PA Yearly Shares OutstandingTNG.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TNG.PA Yearly Total Debt VS Total AssetsTNG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -1.93, we must say that TNG is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.93, TNG is doing worse than 66.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.93
ROIC/WACCN/A
WACC7.92%
TNG.PA Yearly LT Debt VS Equity VS FCFTNG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.54 indicates that TNG may have some problems paying its short term obligations.
  • TNG has a Current ratio of 0.54. This is amonst the worse of the industry: TNG underperforms 81.82% of its industry peers.
  • A Quick Ratio of 0.54 indicates that TNG may have some problems paying its short term obligations.
  • TNG has a Quick ratio of 0.54. This is in the lower half of the industry: TNG underperforms 79.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
TNG.PA Yearly Current Assets VS Current LiabilitesTNG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • TNG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.17%.
  • Looking at the last year, TNG shows a very negative growth in Revenue. The Revenue has decreased by -20.34% in the last year.
  • TNG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.48% yearly.
EPS 1Y (TTM)-31.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.84%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y-29.03%
Revenue growth 5Y-14.48%
Sales Q2Q%36.11%

3.2 Future

  • TNG is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.42% yearly.
  • Based on estimates for the next years, TNG will show a very strong growth in Revenue. The Revenue will grow by 29.60% on average per year.
EPS Next Y55.56%
EPS Next 2Y21.72%
EPS Next 3Y8.51%
EPS Next 5Y-1.42%
Revenue Next Year4.56%
Revenue Next 2Y7.16%
Revenue Next 3Y12.55%
Revenue Next 5Y29.6%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TNG.PA Yearly Revenue VS EstimatesTNG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
TNG.PA Yearly EPS VS EstimatesTNG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TNG. In the last year negative earnings were reported.
  • Also next year TNG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNG.PA Price Earnings VS Forward Price EarningsTNG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNG.PA Per share dataTNG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.72%
EPS Next 3Y8.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for TNG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRANSGENE SA

EPA:TNG (2/26/2026, 7:00:00 PM)

0.856

-0.04 (-4.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)03-24
Inst Owners0.32%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap234.71M
Revenue(TTM)6.08M
Net Income(TTM)-33.97M
Analysts82.86
Price Target1.38 (61.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.96%
PT rev (3m)-23.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)59.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)52.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 38.6
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.02
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.88%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-59.77%
ROA(5y)-43.73%
ROE(3y)-151.05%
ROE(5y)-103.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 100.97%
Cap/Sales 22.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z -1.93
F-Score2
WACC7.92%
ROIC/WACCN/A
Cap/Depr(3y)165.93%
Cap/Depr(5y)113.96%
Cap/Sales(3y)33.44%
Cap/Sales(5y)22.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.84%
EPS Next Y55.56%
EPS Next 2Y21.72%
EPS Next 3Y8.51%
EPS Next 5Y-1.42%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y-29.03%
Revenue growth 5Y-14.48%
Sales Q2Q%36.11%
Revenue Next Year4.56%
Revenue Next 2Y7.16%
Revenue Next 3Y12.55%
Revenue Next 5Y29.6%
EBIT growth 1Y-18.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.42%
EBIT Next 3Y-22.93%
EBIT Next 5YN/A
FCF growth 1Y31.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.14%
OCF growth 3YN/A
OCF growth 5YN/A

TRANSGENE SA / TNG.PA FAQ

What is the ChartMill fundamental rating of TRANSGENE SA (TNG.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to TNG.PA.


What is the valuation status of TRANSGENE SA (TNG.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to TRANSGENE SA (TNG.PA). This can be considered as Overvalued.


Can you provide the profitability details for TRANSGENE SA?

TRANSGENE SA (TNG.PA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for TRANSGENE SA?

The Earnings per Share (EPS) of TRANSGENE SA (TNG.PA) is expected to grow by 55.56% in the next year.